Vitamin B3 compounds compared in laboratory setting

Want NAD+ Without Flushing? Nicotinamide Riboside or Niacin

Nicotinamide riboside (NR) raises blood NAD+ steadily and without the burning, red-faced flush that niacin causes, which is why most people researching NAD+ boosting and healthy ageing choose it over niacin. Niacin still holds its place as an established, clinically monitored option for managing cholesterol. Which one belongs in your routine depends entirely on whether your goal is lipid management or cellular energy support.

TL;DR:

  • Nicotinamide riboside effectively raises blood NAD+ without causing the flushing side effect associated with niacin.
  • Niacin remains the most proven option for cholesterol management but carries risks of flushing and liver toxicity at high doses.
  • NR doses in trials range from 100 mg to 1,000 mg daily, with higher doses producing greater NAD+ increases and good tolerability.
  • People on statins, blood thinners, or with liver conditions should consult a doctor before supplementing with any B3 form, especially high-dose niacin.
  • NR is best suited for boosting cellular energy and aging support, while niacin is still preferred for lipid management when used under medical supervision.
Vivetus
Support Your Healthy Ageing Goals
Explore scientifically backed dietary supplements from Vivetus, designed to support vitality and healthy ageing through convenient online shopping.
Explore Vivetus supplements

Table of Contents

Vitamin B3: three forms, one shared destination

Vitamin B3 is not a single molecule. It is a family of three related compounds, and confusing them is where most supplement shopping goes wrong.

Nicotinic acid (usually just called niacin) is the original form isolated in the 1930s, still used in prescription-strength doses for lipid disorders. Nicotinamide, sometimes called niacinamide, is the form typically found in multivitamins and skincare, chosen because it does not trigger flushing. Nicotinamide riboside is a more recently commercialised precursor, structurally closer to the NAD+ molecule itself, and it takes a shorter metabolic route to get there.

All three eventually feed into the same destination: NAD+ (nicotinamide adenine dinucleotide), a coenzyme every cell needs for energy production and DNA repair. How they get there differs, and that difference is the whole point of this comparison.

  • Nicotinic acid converts to NAD+ via the Preiss-Handler pathway, a route that also produces the flushing response.
  • Nicotinamide follows the salvage pathway, recycling NAD+ breakdown products, but at high doses can inhibit certain enzymes involved in DNA repair.
  • Nicotinamide riboside is phosphorylated by NR kinase enzymes almost immediately into NMN, then NAD+, a distinct kinase-mediated route that preclinical research links to fewer downstream side effects.

Dietary sources overlap but aren’t identical. Niacin and nicotinamide occur widely in meat, fish, and fortified grains, which is why frank dietary deficiency is rare in developed countries. NR occurs naturally only in trace amounts, in milk and certain yeasts, which is why anyone seriously interested in NR relies on supplements rather than food.

Niacin (nicotinic acid): the established cholesterol tool with a catch

Niacin (nicotinic acid): the established cholesterol tool with a catch — overview diagram

Niacin’s clinical reputation rests almost entirely on lipid management. At prescription doses, it lowers LDL cholesterol and triglycerides while raising HDL, and doctors have used it for this purpose for decades. That long track record is precisely why its side-effect profile is so well documented, unlike newer NAD+ boosters still building their evidence base.

The catch is flushing. Within 15 to 30 minutes of taking nicotinic acid, many people experience a burning, reddening sensation across the face and chest. This happens because niacin activates the GPR109A receptor on skin cells, triggering a release of prostaglandins that dilate blood vessels near the surface. It is uncomfortable rather than dangerous for most people, but it’s the single biggest reason patients abandon niacin therapy.

  • Flushing typically peaks within the first hour and fades within two.
  • Extended-release formulations reduce flushing intensity but carry a higher liver-strain risk at equivalent doses.
  • Nicotinamide (the non-flushing B3 form) does not trigger GPR109A, which is why it’s used in skincare and general supplementation instead.

Statistic Callout: An 8-week randomised trial of NR (not niacin) found no flushing at any dose tested, a direct contrast to nicotinic acid’s well-known flush mechanism, which remains one of the clearest tolerability differences between the two forms.

High-dose niacin also carries hepatotoxicity concerns, and clinicians typically monitor liver enzymes during sustained use. It remains a valid tool when cholesterol is the primary target and a patient is under medical supervision, but it was never designed, tested, or marketed as an anti-ageing or NAD+ supplement.

Nicotinamide riboside: how it works and what trials actually show

NR’s appeal comes down to one biochemical shortcut: it skips several conversion steps that nicotinic acid and nicotinamide require, moving through NR kinase enzymes directly to NMN and then NAD+. That efficiency appears to be why it raises blood NAD+ so consistently in trials without the flushing that plagues nicotinic acid.

The clinical data here is genuinely instructive. An 8-week randomised, double-blind, placebo-controlled trial in healthy overweight adults tested NR at 100, 300, and 1,000 milligrams per day and found dose-dependent increases in whole-blood NAD+, with no flushing and no meaningful difference in adverse events compared with placebo. A separate 10-week pilot trial in older adults with mild cognitive impairment found that 1 gram of NR daily increased blood NAD+ roughly 2.6-fold and was well tolerated, though the small sample size meant no measurable cognitive benefit emerged.

Statistic Callout: In the 8-week NIAGEN trial, 1,000 mg daily produced the largest NAD+ increase of the three tested doses, with tolerability holding steady across the full study period, according to the published trial data.

Typical supplement doses on the market range from 250 mg to 500 mg per day, with some products offering up to 1,000 mg, mirroring the upper dose tested in clinical research. NR’s regulatory status in the EU has also firmed up: nicotinamide riboside chloride has been assessed and authorised as a source of niacin for specified food and nutrition uses, with EFSA concluding it is bioavailable as a nicotinamide source under stated conditions. That assessment is part of why NR is now widely stocked on European supplement shelves.

Where NR still falls short of certainty is longevity itself. Researchers studying NR consistently note that while NAD+ increases are well established, large, long-term trials proving sustained clinical benefit beyond that biomarker are still limited. Raising NAD+ is a measurable, reproducible effect. Whether it translates into years of added healthspan is a separate question still being answered.

NAD+ biomarker evidence versus healthspan outcomes

Safety, interactions, and who should be cautious

Side-effect profiles diverge sharply between these two B3 forms, and the differences matter more than most product labels admit.

Nicotinic acid’s main tolerability issue is flushing, but at high sustained doses it also carries genuine liver-strain risk, which is why prescription niacin therapy involves periodic blood monitoring. Nicotinamide, while flush-free, has been associated in some research with gastrointestinal upset and, in a handful of studies using very high doses, changes in platelet counts. NR’s trial record so far shows a cleaner profile: no flushing, no significant adverse-event differences from placebo across multiple controlled studies, though it is a newer compound with a shorter research history.

Regulatory bodies have also drawn a distinction between the forms when setting supplement limits. Assessments from EFSA and national bodies like Germany’s BfR have proposed different maximum levels for nicotinic acid versus nicotinamide in food supplements, recognising that they do not behave identically at high intakes.

  • Anyone on statins, blood thinners, or diabetes medication should speak to a clinician before adding any B3 form, since niacin in particular can interact with lipid-lowering drugs.
  • Pregnant or breastfeeding women should avoid high-dose supplementation of any B3 form beyond standard dietary intake without medical guidance.
  • People with existing liver conditions should treat high-dose niacin with particular caution, given its documented hepatotoxicity signal.

Pro Tip: If you’re switching from a niacin regimen prescribed for cholesterol to an NR supplement for NAD+ support, don’t assume one substitutes for the other; they serve genuinely different clinical purposes, and stopping prescribed niacin without medical advice can undo real progress on lipid numbers.

Head-to-head: choosing based on your actual goal

The right choice here isn’t about which form is “better” in the abstract. It’s about matching the molecule to the job.

  1. Managing cholesterol or triglycerides: Niacin (nicotinic acid) remains the form with decades of clinical evidence behind it for this specific use, though flushing and liver monitoring are part of the deal, and it should only be used under medical supervision at therapeutic doses.
  2. Boosting NAD+ for energy or healthy ageing: Nicotinamide riboside is the better-evidenced choice here, backed by dose-dependent NAD+ increases in controlled human trials with no flushing.
  3. General nutritional adequacy: Standard dietary niacin or nicotinamide intake from food, or a basic multivitamin, is sufficient for most people who show no signs of deficiency.
  4. Cosmetic or skin-focused use: Nicotinamide, not nicotinic acid, is the form used in most topical and oral skin-support products, precisely because it avoids flushing.

Cost and availability tip toward NR for anyone specifically chasing NAD+ support. It’s more expensive per milligram than plain niacin, but you are paying for a cleaner side-effect profile and a mechanism purpose-built for that goal, not repurposing a cholesterol drug for something it was never designed to do. If cholesterol is your actual problem, niacin under clinical supervision still does that job better than NR ever will, because NR has not been studied as a lipid therapy.

What the evidence actually supports right now

The clinical picture is consistent but still incomplete. NAD+ increases from NR are well replicated across independent trials, and the EU’s own assessment of NR chloride’s bioavailability adds regulatory weight behind the biochemistry. What hasn’t caught up yet is proof that raising NAD+ translates into measurable, long-term healthspan gains; that data will take years of larger trials to accumulate.

Vivetus tracks this research closely and publishes it in plain language, including coverage of NMN’s effects on NAD+ and fitness in healthy adults, because NAD+ precursors as a category share overlapping science even when the specific molecules differ.

Whichever form you’re weighing, a few things matter more than brand marketing:

  • Check the exact dose per capsule against the ranges actually tested in trials, not just what’s printed on the front of the packaging.
  • Look for third-party purity testing, since B3 supplements vary widely in manufacturing quality.
  • Treat any supplement decision tied to existing medication, liver conditions, or pregnancy as a conversation for your doctor, not a solo decision.

A straightforward take on the NR versus niacin debate

Most of the marketing around NAD+ boosters glosses over something the trials themselves are honest about: raising a biomarker isn’t the same as proving a benefit you’ll feel. NR earns its reputation because the NAD+ increases are real and repeatable, not because anyone has proven it adds years to your life. Niacin, meanwhile, gets unfairly lumped in with “outdated” supplements when it’s still doing exactly the job it was designed for, just not the job NR shoppers are usually after.

If your bloodwork says your cholesterol needs work, that’s a conversation for your GP, not a supplement aisle decision. If your goal is supporting cellular energy as you age, NR’s tolerability and trial data make it the more sensible starting point. Your medical history is what should tip the decision, not which molecule has better branding this year.

— Jord

Where Vivetus fits into your NAD+ decision

This comparison relies on supplements formulated with vegan, clinically backed ingredients and transparent dosing, assembled in the Netherlands rather than sourced from generic supplement mills.

💪 EnergiePlus bundel

For readers focused specifically on NAD+ support and cellular ageing, the 🔬VitaalPlus bundel combines longevity-focused nutrients designed to complement the NAD+ pathway discussed throughout this article. Those wanting a broader daily energy foundation alongside NAD+ support might look at the 💪 EnergiePlus bundel, while anyone prioritising cognitive and focus support can check the Helder en Scherp bundel. Vivetus also stocks standalone options including NMN, resveratrol, fisetin, quercetin, and pterostilbene for readers building a more targeted stack.

Before buying, check the dose per capsule against the clinical ranges covered earlier, confirm third-party purity testing, and note that free shipping applies on orders over €50. Browse the full product range to compare formulations and decide what fits your specific goal.

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

Sources

FAQ

Is nicotinamide riboside better than niacin?

For NAD+ boosting specifically, yes: NR raises blood NAD+ without causing flushing, which niacin reliably does. For cholesterol management, niacin remains the clinically established option and NR has not been studied for that purpose.

Is nicotinamide better than niacin?

Nicotinamide and niacin (nicotinic acid) serve different roles: nicotinamide avoids the flushing that nicotinic acid causes because it doesn’t activate the same GPR109A receptor pathway, but nicotinic acid is still the form used for lipid therapy. Neither is universally “better”; each fits a different purpose.

Is B3 the same as nicotinamide riboside?

Vitamin B3 is a family name covering nicotinic acid, nicotinamide, and nicotinamide riboside, so NR is one specific form of B3, not a synonym for the whole vitamin. All three eventually convert to NAD+, but through different metabolic routes.

Niacin hasn’t been withdrawn from use, but its therapeutic role has narrowed because newer cholesterol medications often cause fewer side effects than high-dose niacin’s flushing and liver-strain risk. It remains a valid clinical tool under medical supervision, just no longer a first-line choice for every patient.

Can niacin replace nicotinamide riboside for NAD+ support?

Not effectively. Niacin converts to NAD+ through a different pathway and typically causes flushing at the doses that would meaningfully raise NAD+, while NR has been shown in controlled trials to raise NAD+ without that side effect.

What is a typical nicotinamide riboside dosage?

Clinical trials have tested doses between 100 mg and 1,000 mg per day, with the highest tested dose producing the largest NAD+ increase. Most commercial NR supplements, including those on the Vivetus site, list dosing per capsule so you can compare it against these researched ranges.

Regresar al blog